The Global Antithrombotic Drugs Market to Drive at 6.83% of CAGR by 2026

According to a new market research report published by Inkwood Research, the Global Antithrombotic Drugs Market is projected to flourish at 6.83% of CAGR over the forecast years of 2018-2026.

“According to a new market research report published by Inkwood Research, the Global Antithrombotic Drugs Market is projected to flourish at 6.83% of CAGR over the forecast years of 2018-2026”

“Browse 23 market Data Tables and 35 Figures spread over 216 Pages, along with an in-depth TOC on Global Antithrombotic Drugs Market forecast 2018-2026.”

Buy Now

Over the past few decades, antithrombotic drug therapy is primarily being constrained to conventional products such as oral Vitamin K antagonists and heparin. These products are remarked ineffective owing to its complications faced while treating patients. Nevertheless, A varied range of advanced antithrombotic have been introduced or are in the development stage with greater benefits such as improved pharmacological and clinical profiles. These drugs are developed to lift the constraining factors faced by traditional therapies. The offerings of these novel antithrombotic include a more specific action on the coagulation cascade, simpler dosing regimens predictable pharmacodynamics and pharmacokinetics, and few or no laboratory monitoring requirements. These positive inference are set to direct the path of development in the antithrombotic drug market.

Anticoagulants Generate The Highest Revenue In the Antithrombotic Drug Types Market

Anticoagulants are drugs or substances that deter or hinder blood coagulation. Anticoagulants are generally classified as parenteral or oral. These drugs are not effective in dissolving clots that are already present but work as an inhibitor to the disease. Both the drugs groups are applicable in treating blood circulation conditions such as pulmonary embolism and vein thrombosis (DVT). In addition, they are also used in treating arterial conditions; however, arterial disorders have shown more response to antiplatelet agents. In addition, anticoagulants can also be used prophylactically to treat patients on bed rest for prolonged periods due to undergone major surgeries, and those with a previous history of clotting disorders. Hence, the wide application of anticoagulants in treating various diseases is propelling its demand in the antithrombotic drug types market.

To know more about this report, request a free sample copy.

Growth in the Healthcare Industries is leveraging the Antithrombotic Market Globally

The North America healthcare sector is well developed, which is majorly attributable to the United States as it holds the largest healthcare industry in the world. The country’s healthcare expenditure is accounted for approximately $3 trillion annually. During the forecasted period, the sector is expected to leverage promising opportunities for the new generation of entrepreneurs that are striving to fill innovations to the industry, the government and increasingly to the consumers.

On the other hand, the emerging region of Asia Pacific is pacing up with constant development in its healthcare industries. This growth is attracted to the increasing geriatric population, mainly in countries such as China, India and Japan. Few of the key players are also spending huge sum as investments in R&D to boost the healthcare infrastructure in the region, which is also one of the major reasons for the rising healthcare industry in emerging economies.

North American Region Leads the revenue race in the Global Antithrombotic Drugs Market

The whole of North America is witnessing a flourishing growth for antithrombotic agents in the region, owing to the entry of NOACs in the market. Warfarin witnessed elevated growth compared with oral anticoagulant. However, in terms of revenue, the sales of warfarin were diminished due to the presence of generics that are available in the market at 15-20 times lower price when compared to NOACs. Despite side effect such as excessive bleeding, the increased advantages of anticoagulant have outweighed such negative possibilities. However, the unavailability of reversal agents for these drugs has led to reluctance on the part of physicians to prescribe them. Therefore, many vendors are developing reversal agents that are expected to enter the market during the forecasting period.

Few of the top companies present in the global antithrombotic drugs market are Armetheon Inc., Eli Lilly and Company, Abbot laboratories, Boehringer Ingelheim gmbh and Bayer. In the coming years, the market will see many patents expiry. Therefore, this will create new opportunities for new players with more efficacious products.

About Inkwood Research

Inkwood Research specializes in syndicated &customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy; with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us
+1 857-302-4704


Related Report: